Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016 (2016), Article ID 5795712, 7 pages
http://dx.doi.org/10.1155/2016/5795712
Research Article

Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States

1Department of Medicine, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH 44109, USA
2Division of Gastroenterology/Hepatology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH 44109, USA
3Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA

Received 30 January 2016; Revised 23 March 2016; Accepted 17 April 2016

Academic Editor: Fabio Marra

Copyright © 2016 Abhijeet Waghray et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Arvaniti, G. D'Amico, G. Fede et al., “Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis,” Gastroenterology, vol. 139, no. 4, pp. 1246–1256.e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-F. Liaw, C.-T. Yeh, and S.-L. Tsai, “Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection,” The American Journal of Gastroenterology, vol. 95, no. 10, pp. 2978–2980, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. A. R. Bonnel, C. Bunchorntavakul, and K. R. Reddy, “Immune dysfunction and infections in patients with cirrhosis,” Clinical Gastroenterology and Hepatology, vol. 9, no. 9, pp. 727–738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Wiest, M. Lawson, and M. Geuking, “Pathological bacterial translocation in liver cirrhosis,” Journal of Hepatology, vol. 60, no. 1, pp. 197–209, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Ghassemi and G. Garcia-Tsao, “Prevention and treatment of infections in patients with cirrhosis,” Best Practice and Research: Clinical Gastroenterology, vol. 21, no. 1, pp. 77–93, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tandon and G. Garcia-Tsao, “Bacterial infections, sepsis, and multiorgan failure in cirrhosis,” Seminars in Liver Disease, vol. 28, no. 1, pp. 26–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Byl, I. Roucloux, A. Crusiaux, E. Dupont, and J. Devière, “Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patients,” Gastroenterology, vol. 104, no. 5, pp. 1492–1497, 1993. View at Google Scholar · View at Scopus
  8. S.-S. Wang, F.-Y. Lee, C.-C. Chan et al., “Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection,” Clinical Science, vol. 98, no. 4, pp. 419–425, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Fernández, M. Navasa, J. Gómez et al., “Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis,” Hepatology, vol. 35, no. 1, pp. 140–148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Borzio, F. Salerno, L. Piantoni et al., “Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study,” Digestive and Liver Disease, vol. 33, no. 1, pp. 41–48, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. W. R. Caly and E. Strauss, “A prospective study of bacterial infections in patients with cirrhosis,” Journal of Hepatology, vol. 18, no. 3, pp. 353–358, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. D. R. Feikin, A. Schuchat, M. Kolczak et al., “Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997,” American Journal of Public Health, vol. 90, no. 2, pp. 223–229, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Viasus, C. Garcia-Vidal, J. Castellote et al., “Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores,” Medicine, vol. 90, no. 2, pp. 110–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-H. Hung, C.-W. Tseng, Y.-H. Hsieh, K.-C. Tseng, C.-C. Tsai, and C.-C. Tsai, “High mortality of pneumonia in cirrhotic patients with ascites,” BMC Gastroenterology, vol. 13, article 25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. P. L. Almasio and P. Amoroso, “HAV infection in chronic liver disease: a rationale for vaccination,” Vaccine, vol. 21, no. 19-20, pp. 2238–2241, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. E. B. Keeffe, “Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination,” The American Journal of Medicine, vol. 118, no. 10, supplement, pp. 21S–27S, 2005. View at Publisher · View at Google Scholar
  17. R. S. Koff, “Risks associated with hepatitis A and hepatitis B in patients with hepatitis C,” Journal of Clinical Gastroenterology, vol. 33, no. 1, pp. 20–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Reiss and E. B. Keeffe, “Review article: hepatitis vaccination in patients with chronic liver disease,” Alimentary Pharmacology and Therapeutics, vol. 19, no. 7, pp. 715–727, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. W. G. E. Cooksley, “What did we learn from the Shanghai hepatitis A epidemic?” Journal of Viral Hepatitis, vol. 7, supplement 1, pp. 1–3, 2000. View at Google Scholar · View at Scopus
  20. G. Yao, “Clinical spectrum and natural history of viral hepatitis a in 1988 shanghai epidemic,” in Viral Hepatitis and Liver Disease, F. B. Hollinger, S. M. Lemon, and H. S. Margolic, Eds., pp. 76–78, Williams and Williams, Baltimore, Md, USA, 1991. View at Google Scholar
  21. E. B. Keeffe, “Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?” The American Journal of Gastroenterology, vol. 90, no. 2, pp. 201–205, 1995. View at Google Scholar · View at Scopus
  22. S. Vento, T. Garofano, C. Renzini et al., “Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C,” The New England Journal of Medicine, vol. 338, no. 5, pp. 286–290, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. W. M. Lee, “Hepatitis B virus infection,” The New England Journal of Medicine, vol. 337, no. 24, pp. 1733–1745, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Bianchi, G. Marchesini, M. Zoli, E. Bugianesi, A. Fabbri, and E. Pisi, “Prognostic significance of diabetes in patients with cirrhosis,” Hepatology, vol. 20, no. 1, part 1, pp. 119–125, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. R. de Marco, F. Locatelli, G. Zoppini, G. Verlato, E. Bonora, and M. Muggeo, “Cause-specific mortality in type 2 diabetes. The Verona diabetes study,” Diabetes Care, vol. 22, no. 5, pp. 756–761, 1999. View at Publisher · View at Google Scholar
  26. S. A. Harrison, “Liver disease in patients with diabetes mellitus,” Journal of Clinical Gastroenterology, vol. 40, no. 1, pp. 68–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Holstein, S. Hinze, E. Thießen, A. Plaschke, and E.-H. Egberts, “Clinical implications of hepatogenous diabetes in liver cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 17, no. 6, pp. 677–681, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. S. E. Geerlings and A. I. M. Hoepelman, “Immune dysfunction in patients with diabetes mellitus (DM),” FEMS Immunology and Medical Microbiology, vol. 26, no. 3-4, pp. 259–265, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Y. Peleg, T. Weerarathna, J. S. McCarthy, and T. M. E. Davis, “Common infections in diabetes: pathogenesis, management and relationship to glycaemic control,” Diabetes/Metabolism Research and Reviews, vol. 23, no. 1, pp. 3–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Elkrief, P. Chouinard, N. Bendersky et al., “Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C,” Hepatology, vol. 60, no. 3, pp. 823–831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Szmuness, C. E. Stevens, E. J. Harley et al., “Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States,” The New England Journal of Medicine, vol. 303, no. 15, pp. 833–841, 1980. View at Google Scholar
  32. J. N. Zuckerman, “Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines,” Journal of Medical Virology, vol. 78, no. 2, pp. 169–177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. F. André, P. Van Damme, A. Safary, and J. Banatvala, “Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use,” Expert Review of Vaccines, vol. 1, no. 1, pp. 9–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Ghany, D. B. Strader, D. L. Thomas, and L. B. Seeff, “American Association for the Study of Liver D. Diagnosis, management, and treatment of hepatitis C: an update,” Hepatology, vol. 49, no. 4, pp. 1335–1374, 2009. View at Publisher · View at Google Scholar
  35. Advisory Committee on Immunization Practices, “Recommended adult immunization schedule: United States, 2013,” Annals of Internal Medicine, vol. 158, no. 3, pp. 191–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. E. Mast, C. M. Weinbaum, A. E. Fiore et al., “A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults,” Morbidity and Mortality Weekly Report, vol. 55, no. 16, pp. 1–33, 2006. View at Google Scholar
  37. E. E. Mast, H. S. Margolis, A. E. Fiore et al., “A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents,” MMWR Recommendations and Reports, vol. 54, no. 16, pp. 1–31, 2005. View at Google Scholar · View at Scopus
  38. C. Fiuza, M. Salcedo, G. Clemente, and J. M. Tellado, “In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease,” The Journal of Infectious Diseases, vol. 182, no. 2, pp. 526–533, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Christou, G. Pappas, and M. E. Falagas, “Bacterial infection-related morbidity and mortality in cirrhosis,” American Journal of Gastroenterology, vol. 102, no. 7, pp. 1510–1517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. M. Younossi and M. Stepanova, “Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population,” Hepatology, vol. 54, no. 4, pp. 1167–1178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Hernandez, N. K. Hasson, and R. Cheung, “Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities,” American Journal of Gastroenterology, vol. 104, no. 8, pp. 1961–1967, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. R. Kramer, C. Y. Hachem, F. Kanwal, M. Mei, and H. B. El-Serag, “Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection,” Hepatology, vol. 53, no. 1, pp. 42–52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Wörns, A. Teufel, S. Kanzler et al., “Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases,” The American Journal of Gastroenterology, vol. 103, no. 1, pp. 138–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Moreau, P. Delègue, F. Pessione et al., “Clinical characteristics and outcome of patients with cirrhosis and refractory ascites,” Liver International, vol. 24, no. 5, pp. 457–464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Nishida, S. Tsuji, M. Tsujii et al., “Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis,” The American Journal of Gastroenterology, vol. 101, no. 1, pp. 70–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. R. Arguedas, A. Johnson, M. A. Eloubeidi, and M. B. Fallon, “Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients,” Hepatology, vol. 34, no. 1, pp. 28–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Calycine, G. Smallwood, J. Halcomb, M. W. Fried, T. D. Boyer, and D. H. Van Thiel, “Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation,” Liver Transplantation and Surgery, vol. 4, no. 2, pp. 128–187, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. J. A. Dumot, D. S. Barnes, Z. Younossi et al., “Immunogenicity of hepatitis A vaccine in decompensated liver disease,” The American Journal of Gastroenterology, vol. 94, no. 6, pp. 1601–1604, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. T. M. McCashland, L. C. Preheim, and M. J. Gentry-Nielsen, “Pneumococcal vaccine response in cirrhosis and liver transplantation,” Journal of Infectious Diseases, vol. 181, no. 2, pp. 757–760, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. G. A. Smallwood, C. T. Coloura, E. Martinez, A. C. Stieber, and T. G. Heffron, “Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine?” Transplantation Proceedings, vol. 34, no. 8, pp. 3289–3290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. H. Woolf, “The power of prevention and what it requires,” The Journal of the American Medical Association, vol. 299, no. 20, pp. 2437–2439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. R. J. Jacobs, A. S. Meyerhoff, and S. Saab, “Immunization needs of chronic liver disease patients seen in primary care versus specialist settings,” Digestive Diseases and Sciences, vol. 50, no. 8, pp. 1525–1531, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. T. S. Loo, R. B. Davis, L. A. Lipsitz et al., “Electronic medical record reminders and panel management to improve primary care of elderly patients,” Archives of Internal Medicine, vol. 171, no. 17, pp. 1552–1558, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Weber, F. Bloom, S. Pierdon, and C. Wood, “Employing the electronic health record to improve diabetes care: a multifaceted intervention in an integrated delivery system,” Journal of General Internal Medicine, vol. 23, no. 4, pp. 379–382, 2008. View at Publisher · View at Google Scholar · View at Scopus